相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cost-utility analysis of adjuvant goserelin (Zoladex) and adjuvant chemotherapy in premenopausal women with breast cancer
Tsui Fen Cheng et al.
BMC CANCER (2012)
Patient preferences for chemotherapies used in breast cancer
Kathleen Beusterien et al.
INTERNATIONAL JOURNAL OF WOMENS HEALTH (2012)
Systematic reviews and economic evaluations conducted for the National Institute for Health and Clinical Excellence in the United Kingdom: A game of two halves?
Michael F. Drummond et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2008)
Utilities should not be multiplied - Evidence from the preference-based scores in the United States
Alex Z. Fu et al.
MEDICAL CARE (2008)
Tamoxifen for breast cancer risk reduction - Impact of alternative approaches to quality-of-life adjustment on cost-effectiveness analysis
Joy Melnikow et al.
MEDICAL CARE (2008)
Cost-effectiveness analysis of anastrozole vs tamoxifen in adjuvant therapy for early stage breast cancer in the United Kingdom: the 5-year completed treatment analysis of the ATAC ('Arimidex', Tamoxifen alone or in combination) trial
R. Mansel et al.
BRITISH JOURNAL OF CANCER (2007)
Health state utilities for metastatic breast cancer
A. Lloyd et al.
BRITISH JOURNAL OF CANCER (2006)
Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer
CC Sun et al.
SUPPORTIVE CARE IN CANCER (2005)
Adjuvant chemotherapy for breast cancer: How presentation of recurrence risk influences decision-making
C Chao et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
An Internet-based utility assessment of breast hypertrophy
WT Chang et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2001)
Cost effectiveness of treatment options in advanced breast cancer in the UK
RE Brown et al.
PHARMACOECONOMICS (2001)
分享论文
